rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2008-1-1
|
pubmed:abstractText |
Fibroblast growth factor-23 (FGF23) is a circulating factor involved in phosphate (Pi) and vitamin D metabolism. Serum FGF23 is increased at later stages of chronic kidney disease due to chronic hyperphosphatemia and decreased renal clearance. Recent studies also indicate that FGF23 may directly regulate the expression of parathyroid hormone (PTH) in vitro. Therefore, the objective of the current study was to determine the relationship between FGF23, PTH, and other biochemistries in vivo in subjects with no history of renal disease.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CST3 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Cystatin C,
http://linkedlifedata.com/resource/pubmed/chemical/Cystatins,
http://linkedlifedata.com/resource/pubmed/chemical/Fibroblast Growth Factors,
http://linkedlifedata.com/resource/pubmed/chemical/PTH protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Parathyroid Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphates,
http://linkedlifedata.com/resource/pubmed/chemical/Serum Albumin,
http://linkedlifedata.com/resource/pubmed/chemical/fibroblast growth factor 23
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1479-683X
|
pubmed:author |
pubmed-author:GrundbergElinE,
pubmed-author:JonssonKenneth BKB,
pubmed-author:KarlssonMagnusM,
pubmed-author:KrajisnikTijanaT,
pubmed-author:LarssonTobias ETE,
pubmed-author:LjunggrenOstenO,
pubmed-author:MallminHansH,
pubmed-author:MarsellRichardR,
pubmed-author:MellströmDanD,
pubmed-author:OhlssonClaesC,
pubmed-author:OrwollEricE
|
pubmed:issnType |
Electronic
|
pubmed:volume |
158
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
125-9
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:18166826-Aged,
pubmed-meshheading:18166826-Aged, 80 and over,
pubmed-meshheading:18166826-Calcium,
pubmed-meshheading:18166826-Cohort Studies,
pubmed-meshheading:18166826-Cystatin C,
pubmed-meshheading:18166826-Cystatins,
pubmed-meshheading:18166826-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:18166826-Fibroblast Growth Factors,
pubmed-meshheading:18166826-Glomerular Filtration Rate,
pubmed-meshheading:18166826-Humans,
pubmed-meshheading:18166826-Kidney,
pubmed-meshheading:18166826-Linear Models,
pubmed-meshheading:18166826-Male,
pubmed-meshheading:18166826-Multivariate Analysis,
pubmed-meshheading:18166826-Parathyroid Hormone,
pubmed-meshheading:18166826-Phosphates,
pubmed-meshheading:18166826-Regression Analysis,
pubmed-meshheading:18166826-Serum Albumin,
pubmed-meshheading:18166826-Sweden
|
pubmed:year |
2008
|
pubmed:articleTitle |
Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men.
|
pubmed:affiliation |
Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|